L. A. Litzky

Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study.

M. Goldman, John F. Engelhardt, James M. Wilson, 1995, Human gene therapy.

Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer.

H. Hwang, W. Smythe, A. Elshami, 1995, American journal of respiratory cell and molecular biology.

Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a.

James M. Wilson, J. Wilson, L. Litzky, 1994, Human gene therapy.

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

James M. Wilson, J. Wilson, K. Molnar-Kimber, 1998, Human gene therapy.

Evaluation of EGFR mutation status in cytology specimens: An institutional experience

A. Sepulveda, D. Aisner, Z. Baloch, 2013, Diagnostic cytopathology.

Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.

J. Morris, U. Rodeck, C. Kari, 1995, The American journal of pathology.

Primary graft failure following lung transplantation.

J. Bavaria, H. Palevsky, L. Kaiser, 1998, Chest.

Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy

M. Lanuti, S. Albelda, K. Amin, 2001, Gene Therapy.

Serotonin reduction in post-acute sequelae of viral infection

M. Peluso, K. Wellen, A. Greenplate, 2023, Cell.